These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 31913203)
1. Immunotherapy for stone disease. Dominguez-Gutierrez PR; Kwenda EP; Khan SR; Canales BK Curr Opin Urol; 2020 Mar; 30(2):183-189. PubMed ID: 31913203 [TBL] [Abstract][Full Text] [Related]
2. Macrophage Function in Calcium Oxalate Kidney Stone Formation: A Systematic Review of Literature. Taguchi K; Okada A; Unno R; Hamamoto S; Yasui T Front Immunol; 2021; 12():673690. PubMed ID: 34108970 [TBL] [Abstract][Full Text] [Related]
3. Calcium Oxalate Differentiates Human Monocytes Into Inflammatory M1 Macrophages. Dominguez-Gutierrez PR; Kusmartsev S; Canales BK; Khan SR Front Immunol; 2018; 9():1863. PubMed ID: 30186283 [TBL] [Abstract][Full Text] [Related]
4. Short Chain Fatty Acids Prevent Glyoxylate-Induced Calcium Oxalate Stones by GPR43-Dependent Immunomodulatory Mechanism. Jin X; Jian Z; Chen X; Ma Y; Ma H; Liu Y; Gong L; Xiang L; Zhu S; Shu X; Qi S; Li H; Wang K Front Immunol; 2021; 12():729382. PubMed ID: 34675921 [TBL] [Abstract][Full Text] [Related]
5. Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals. Zhu W; Zhao Z; Chou F; Zuo L; Liu T; Yeh S; Bushinsky D; Zeng G; Chang C Cell Death Dis; 2019 Mar; 10(4):275. PubMed ID: 30894518 [TBL] [Abstract][Full Text] [Related]
6. Macrophage polarization regulation shed lights on immunotherapy for CaOx kidney stone disease. Zhu W; Qiong D; Changzhi X; Meiyu J; Hui L Biomed Pharmacother; 2024 Oct; 179():117336. PubMed ID: 39180792 [TBL] [Abstract][Full Text] [Related]
7. Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation. Khan SR; Canales BK; Dominguez-Gutierrez PR Nat Rev Nephrol; 2021 Jun; 17(6):417-433. PubMed ID: 33514941 [TBL] [Abstract][Full Text] [Related]
8. Development of a two-stage model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 2 in vivo studies of stone growth on biomimetic Randall's plaque. O'Kell AL; Lovett AC; Canales BK; Gower LB; Khan SR Urolithiasis; 2019 Aug; 47(4):335-346. PubMed ID: 30218116 [TBL] [Abstract][Full Text] [Related]
9. An Immune Atlas of Nephrolithiasis: Single-Cell Mass Cytometry on SIRT3 Knockout and Calcium Oxalate-Induced Renal Injury. Zhang W; Li L; Zhang T; Gao X; Wang Z; Ming S; Fang Z; Liu M; Dong H; Zhu B; Liao J; Zeng J; Peng Y; Gao X J Immunol Res; 2021; 2021():1260140. PubMed ID: 34849375 [TBL] [Abstract][Full Text] [Related]
10. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function. Robertson WG Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799 [TBL] [Abstract][Full Text] [Related]
11. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique. Robertson WG Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407 [TBL] [Abstract][Full Text] [Related]
12. Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis. Liu H; Yang X; Tang K; Ye T; Duan C; Lv P; Yan L; Wu X; Chen Z; Liu J; Deng Y; Zeng G; Xing J; Ye Z; Xu H Theranostics; 2020; 10(16):7319-7334. PubMed ID: 32641994 [TBL] [Abstract][Full Text] [Related]
13. Atorvastatin Decreases Renal Calcium Oxalate Stone Deposits by Enhancing Renal Osteopontin Expression in Hyperoxaluric Stone-Forming Rats Fed a High-Fat Diet. Liu CJ; Tsai YS; Huang HS Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328466 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of sirtuin 1 attenuates calcium oxalate-induced kidney injury by promoting macrophage polarization. Song BF; Li BJ; Ning JZ; Xia YQ; Ye ZH; Yuan TH; Yan XZ; Li L; Zhou XJ; Rao T; Li W; Cheng F Int Immunopharmacol; 2023 Aug; 121():110398. PubMed ID: 37301123 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of AT1R/IP3/IP3R-mediated Ca Hong SY; Yang YY; Wang SG; Qin BL Chem Biol Interact; 2023 Sep; 382():110636. PubMed ID: 37454925 [TBL] [Abstract][Full Text] [Related]
16. CCR2 antagonist attenuates calcium oxalate-induced kidney oxidative stress and inflammation by regulating macrophage activation. Wang X; Xie L; Liu C Exp Anim; 2024 May; 73(2):211-222. PubMed ID: 38199255 [TBL] [Abstract][Full Text] [Related]
17. Two distinct phenotypes of calcium oxalate stone formers could imply different long-term risks for renal function. Williams JC; Bowen WS; Lingeman JE; Rivera M; Worcester EM; El-Achkar TM Urolithiasis; 2024 Sep; 52(1):133. PubMed ID: 39340639 [TBL] [Abstract][Full Text] [Related]
18. Collagen fibrils and cell nuclei are entrapped within Randall's plaques but not in CaOx matrix overgrowth: A microscopic inquiry into Randall's plaque stone pathogenesis. Canela VH; Bledsoe SB; Worcester EM; Lingeman JE; El-Achkar TM; Williams JC Anat Rec (Hoboken); 2022 Jul; 305(7):1701-1711. PubMed ID: 34825513 [TBL] [Abstract][Full Text] [Related]
19. Fu-Fang-Jin-Qian-Cao herbal granules protect against the calcium oxalate-induced renal EMT by inhibiting the TGF-β/smad pathway. Liu WR; Lu HT; Zhao TT; Ding JR; Si YC; Chen W; Hou JB; Gao SY; Dong X; Yu B; Guo ZY; Lu JR Pharm Biol; 2020 Dec; 58(1):1115-1122. PubMed ID: 33191819 [TBL] [Abstract][Full Text] [Related]
20. [The role of cell-crystal reaction mediated inflammation in the formation of intrarenal calcium oxalate crystals]. Deng YL; Liu YL; Tao ZW; Wang X Zhonghua Wai Ke Za Zhi; 2018 Oct; 56(10):733-736. PubMed ID: 30369150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]